Munafa Stock Market Course + Intraday & FNO calls 
SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE
Sun Pharma Advanced Research Company Limited Complete list of announcements declared & dividend announcements by Sun Pharma Advanced Research Company Limited SPARC
Sun Pharma Advanced Research Company Limited SPARC listed on NSE and deals in PharmaceuticalsAnnouncements and dividends declared by Sun Pharma Advanced Research Company Limited SPARC
Sun Pharma Share Price Live Updates: Sun Pharma Posts 0.04% Return Over the Last Week
Announcement as on 10 November 2025
New launches and R&D pipeline bolster Sun Pharma's long-term growth outlook
Sun Pharma reported robust global specialty growth and resilient domestic sales in Q3, despite US generics headwinds. Recent product launches and pipeline advancements, including Unloxcyt and Leqselvi, are poised to drive long-term growth. Analysts maintai
Announcement as on 10 November 2025
Sun Pharma’s US innovative drug sales surpass generics for the first time
Sun Pharma's U.S. innovative medicine sales have surpassed generics for the first time, driven by key products like Ilumya and Cequa. The launch of Leqselvi for alopecia has been well-received, with further growth anticipated from upcoming launches like Un
Announcement as on 06 November 2025
Sun Pharma's US innovative drug sales surpass generics for first time
Sun Pharma is open to expanding its US manufacturing capabilities in response to the Trump administration's 100% tariff on medicines. The company is evaluating its current footprint and considering localization options, though the tariff's impact on its pr
Announcement as on 05 November 2025
Sun Pharma Q2 Preview: PAT may rise 2% YoY; Leqselvi spending to weigh on margins
Sun Pharma is expected to report modest Q2 FY26 earnings growth, with PAT likely up 2% YoY and revenue rising 7%. Analysts cite Leqselvi launch costs, weak Taro performance, and high R&D spend as margin drags, even as domestic and specialty segments co
Announcement as on 04 November 2025
Announcements by Sun Pharma Advanced Research Company Limited first page | Next page | Prev page |
SPARC Sun Pharma Advanced Research Company Limited current price & indicator signals
Recent prices of SPARC Sun Pharma Advanced Research Company Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 09 Tue Dec 2025 | 142.19 | 136.90 to 144.24 | 1.6% | 0.32 times |
| 08 Mon Dec 2025 | 139.95 | 137.55 to 153.93 | -8.49% | 0.33 times |
| 05 Fri Dec 2025 | 152.94 | 150.21 to 157.99 | 0.55% | 0.68 times |
| 04 Thu Dec 2025 | 152.10 | 146.94 to 159.95 | 0.36% | 2.65 times |
| 03 Wed Dec 2025 | 151.55 | 149.65 to 179.43 | -5.88% | 5.18 times |
| 02 Tue Dec 2025 | 161.02 | 134.19 to 161.02 | 19.99% | 1.11 times |
| 01 Mon Dec 2025 | 134.19 | 133.30 to 135.48 | -0.24% | 0.01 times |
| 28 Fri Nov 2025 | 134.51 | 133.41 to 137.43 | -0.84% | 0.01 times |
| 27 Thu Nov 2025 | 135.65 | 132.30 to 136.91 | 1.43% | 0.01 times |
| 26 Wed Nov 2025 | 133.74 | 132.30 to 135.83 | 0.69% | 0.01 times |
| 25 Tue Nov 2025 | 132.83 | 131.81 to 133.99 | -0.51% | 0.01 times |
| 24 Mon Nov 2025 | 133.51 | 132.20 to 137.56 | -1.84% | 0.02 times |
Videos related to: SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
